Clinical Trials Sponsored by Koya Medical, Inc.

Total 2824 results

Koya Medical, Inc.

Recruiting

A Non-randomized, Open-Label Study to Evaluate the Safety and Effectiveness of Insight® Pro Device for Evaluating Lymphatic and Venous Disorders (VOLGA) (VOLGA)

Lymphedema | Edema | Venous Insufficiency of Leg | Chronic Venous Insufficiency

United States
Koya Medical, Inc.

Completed

A Clinical Study to Evaluate the Effectiveness of a Novel Portable Non-Pneumatic Active Compression Device vs. an Advanced Pneumatic Compression Device for Treating Lower Extremity Lymphedema (TEAYS)

Lymphedema | Venous Insufficiency | Chronic Venous Insufficiency | Lymphedema, Lower Limb | Lymphedema of Leg

United States
Koya Medical, Inc.

Completed

A Non-randomized, Open-Label Study to Evaluate the Safety and Effectiveness of Dayspring Active Wearable Compression Technology for Treating Lower Extremity Lymphedema (TIBER)

Lymphedema | Secondary Lymphedema | Chronic Venous Insufficiency | Lymphedema Lower Extremity

United States
Koya Medical, Inc.

Completed

Clinical Evaluation of a Novel Wearable Compression Technology in the Treatment of Lymphedema, An Open-Label Controlled Study (DAYSPRING)

Quality of Life | Lymphedema | Lymphedema of Upper Arm | Breast Cancer Related Lymphedema

United States
Koya Medical, Inc.

Recruiting

A Multi-center Randomized Control Cross-over Study to Evaluate the Safety and Effectiveness of the Dayspring Active Wearable Compression Device vs. an Advanced Pneumatic Compression Device for Treating Breast Cancer Related Lymphedema (NILE)

Lymphedema | Lymphedema of Upper Arm | Lymphedema, Breast Cancer

United States
Koya Medical, Inc.

Recruiting

A Non-randomized, Open-Label Study to Evaluate the Safety and Effectiveness of the Dayspring Technology for Patients With Breast Cancer Related Lymphedema (BCRL) After Lymphatic Surgery (TIGRIS)

Lymphedema | Lymphedema, Breast Cancer | Lymphedema Arm

United States
Kona Medical Inc.

Completed

Renal Denervation Using Externally Focused Therapeutic Ultrasound

Hypertension

Czech Republic, New Zealand
Kona Medical Inc.

Unknown

Sham Controlled Study of Renal Denervation for Subjects With Uncontrolled Hypertension (WAVE_IV)

Hypertension

Germany, United Kingdom, Poland, Australia, Austria, Colombia, Czech Republic, New Zealand
Kona Medical Inc.

Completed

Feasibility Study to Evaluate Renal Denervation Using Focused Ultrasound

Hypertension

Canada, Australia, Czech Republic
Kona Medical Inc.

Completed

A Safety Evaluation of Renal Denervation Using Focused Therapeutic Ultrasound on Patients With Refractory Hypertension

Hypertension

Australia
Kona Medical Inc.

Unknown

Sham Controlled Study of Renal Denervation for Untreated Stage I and II Hypertension

Hypertension
Keya Medical

Active, not recruiting

A CCTA Image Assisted Triage Software for the Assessment of Patients With Suspected Coronary Artery Disease

Coronary Heart Disease

China
Kowa Research Institute, Inc.

Recruiting

Study to Evaluate the Efficacy and Safety of K-877-ER and CSG452 in Participants With NASH With Liver Fibrosis

NASH

United States, Canada, Spain, Japan, Bulgaria
Kowa Research Institute, Inc.

Completed

A Study to Investigate the Safety and Efficacy of Ripasudil (K-321) Eye Drops After Cataract Surgery

Corneal Edema After Cataract Surgery

United States, Puerto Rico
Kowa Research Institute, Inc.

Completed

Study to Evaluate the Efficacy and Safety of K-877 in Adult Patients With Fasting High Triglyceride Levels and Normal Renal Function

Severe Hypertriglyceridemia

United States, Hungary, Belarus, Bulgaria, Czechia, Georgia, Poland, Russian Federation, Ukraine
Kowa Research Institute, Inc.

Completed

Study to Evaluate the Efficacy and Safety of K-877 in Adult Patients With Fasting High Triglyceride Levels and Mild or Moderate Renal Impairment

Severe Hypertriglyceridemia

United States, Czechia, Belarus, Hungary, Russian Federation, Poland, Bulgaria, Georgia, Ukraine
Kowa Research Institute, Inc.

Completed

Drug-Drug Interaction of Lopinavir/Ritonavir on Pitavastatin

Healthy Volunteers

United States
Kowa Research Institute, Inc.

Completed

Compare the Pharmacokinetic of K-877 Controlled Release (CR) and Immediate Release (IR) Tablets in Healthy Adults.

Healthy

United States
Kowa Research Institute, Inc.

Completed

Study to Compare Kowa OCT Bi-μ and the Optovue iVue 100 (OCT)

Glaucoma | Healthy | Retinal Disease

United States
Kowa Research Institute, Inc.

Completed

Evaluation of Absorption, Metabolism, and Excretion and Estimation of the Absolute Bioavailability of K-312

Dyslipidemia

United States
Kowa Research Institute, Inc.

Completed

A Comparison Study to Evaluate the Pharmacokinetics and Safety of NK-104-CR in Healthy Adult Volunteers

Hyperlipidemia

United States
Hoya Surgical Optics, Inc.

Completed

Clinical Study of a UV-Absorbing Acrylic Posterior Chamber Intraocular Lens (HMY)

Aphakia

United States
Kowa Research Institute, Inc.

Completed

A Thorough Corrected QT Interval Trial

Dyslipidemia

United States
Hoya Surgical Optics, Inc.

Completed

Visual Quality Following Aspheric Intraocular Lens (IOL) Implantation - a Comparative Clinical Study (751)

Cataract | Aphakia

Australia
Hoya Surgical Optics, Inc.

Completed

Comparison of Aspheric Toric & Non-toric Aphakic Intraocular Lenses (COAST)

Cataract | Aphakia

United States
Kowa Research Institute, Inc.

Completed

Drug-Drug Interaction Study in Healthy Adult Volunteers

Healthy

United States
Kowa Research Institute, Inc.

Completed

Drug-Drug Interaction Study in Healthy Adult Volunteers

Healthy

United States
Kowa Research Institute, Inc.

Completed

Drug-Drug Interaction Study in Health Adult Volunteers

Healthy

United States
Kowa Research Institute, Inc.

Completed

Study Comparing the Pharmacokinetics, Pharmacodynamics, and Safety of K-312 in Healthy Adult Volunteers

Safety and Tolerability

United States
Kowa Research Institute, Inc.

Completed

Drug-Drug Interaction of Cardizem LA (Diltiazem Hydrochloride) on Pitavastatin

Healthy

United States
Kowa Research Institute, Inc.

Completed

Prevail-Us: A Study Of Pitavastatin 4 mg Vs. Pravastatin 40 mg In Patients With Primary Hyperlipidemia Or Mixed Dyslipidemia (PREVAIL-US)

Mixed Dyslipidemia | Primary Dyslipidemia

United States
Kowa Research Institute, Inc.

Completed

A Study Comparing the Safety, Tolerance, and Efficacy of Various Doses of SK-0403 Versus Placebo and Sitagliptin 100 mg in Patients Not Well-Controlled on Metformin Therapy

Type 2 Diabetes

United States
Kowa Research Institute, Inc.

Recruiting

Study to Evaluate the Efficacy and Safety of K-808 (Pemafibrate) in Participants With Primary Biliary Cholangitis (PBC) With Inadequate Response to Ursodeoxycholic Acid (UDCA) and/or Obeticholic Acid (OCA) Treatment.

Primary Biliary Cholangitis

United States, Japan
Kowa Research Institute, Inc.

Completed

A Study to Confirm the Efficacy and Safety of K-161 Ophthalmic Solution for Treatment of Moderate to Severe Dry Eye Disease

Dry Eye Disease

United States
Kowa Research Institute, Inc.

Completed

Study to Demonstrate the Bioequivalence of Single Oral Administration of K-001 Relative to Single Oral Coadministration of Separate Tablets of K-877-ER and CSG452

Healthy

United States
Kowa Research Institute, Inc.

Completed

A Study Assessing the Safety, Efficacy, and Optimum Dosage of K-161 in Subjects With Moderate to Severe Dry Eye Disease

Dry Eye Disease

United States
Kowa Research Institute, Inc.

Completed

Study to Investigate the Safety and Efficacy of K-321 in Patients With Fuchs Endothelial Corneal Dystrophy (FECD) Following Descemetorhexis

Fuchs' Endothelial Corneal Dystrophy

United States, Australia, Germany, Spain, Denmark
Kowa Research Institute, Inc.

Terminated

A Study to Evaluate the Efficacy and Safety of K-285 Compared With Menthol Gel for the Treatment of Delayed Onset Muscle Soreness (DOMS) in the Lower Extremity

Acute Pain

United States
Kowa Research Institute, Inc.

Withdrawn

Safety and Efficacy Comparison Study of NK-104-CR (Controled Release) in Patients With Primary Hyperlipidemia or Mixed Dyslipidemia

Dyslipidemia | Hyperlipidemia

United States
Kowa Research Institute, Inc.

Completed

Evaluate the Safety, Tolerability, & Pharmacokinetics of K-285 Compared With Indomethacin Capsule in Healthy Adults

Healthy

United States
Kowa Research Institute, Inc.

Completed

Drug-Drug Interaction Study to Assess the Effects of Multi Dose Clopidogrel on the Pharmacokinetics of Single-Dose K-877 in Healthy Adult Volunteers

Healthy

United States
Kowa Research Institute, Inc.

Completed

Drug-Drug Interaction Study in Healthy Adult Volunteers

Healthy

United States
Hoya Surgical Optics, Inc.

Completed

Comparison of the Hoya Surgical Optics (HSO) iSert 251 Posterior Chamber Aspheric Aphakic Intraocular Lens to Historical / Literature Controls.

Cataract | Aphakia

United States
Kowa Research Institute, Inc.

Completed

Drug-Drug Interaction Study in Healthy Adult Volunteers

Healthy

United States
Kowa Research Institute, Inc.

Completed

Drug-Drug Interaction Study to Assess the Effects of Steady State Pitavastatin 4 mg or Rosuvastatin 40 mg on Steady-State Warfarin in Healthy Adult Volunteers

Healthy

United States
Kowa Research Institute, Inc.

Completed

Safety and Efficacy of K-134 for the Treatment of Intermittent Claudication

Intermittent Claudication

United States, Russian Federation
Kowa Research Institute, Inc.

Completed

A Trial of the Safety and Efficacy of K-604 for the Treatment of Atherosclerosis

Atherosclerosis

United States
Kowa Research Institute, Inc.

Completed

A Multicenter, Open Label, Single Dose Study to Evaluate the Effect of Renal Insufficiency on the Pharmacokinetics of SK 0403

Type 2 Diabetes Mellitus

United States
Kowa Research Institute, Inc.

Recruiting

A Study to Investigate the Safety and Efficacy of K-321 Eye Drops After Simultaneous Cataract Surgery and Descemetorhexis in Participants With Fuchs Endothelial Corneal Dystrophy (FECD)

Fuchs Endothelial Corneal Dystrophy

United States, United Kingdom, Spain, Germany, Canada, Denmark
Kowa Research Institute, Inc.

Recruiting

A Study to Evaluate the Safety and Efficacy of K-321 Eye Drops After Descemetorhexis in Participants With Fuchs Endothelial Corneal Dystrophy (FECD)

Fuchs Endothelial Corneal Dystrophy

United States, Germany, Spain, Canada, United Kingdom, Denmark

3

Subscribe